Nikkiso Cryogenic Services and Taikkiso Co., Ltd. Establish New Service Agreement

IRVINE, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) — Cryogenic Industries Service Companies (NCS), a functional unit of Nikkiso Cryogenic Industries’ Clean Energy and Industrial Gases Group (“Group”), has entered into a Collaboration Agreement with Taikkiso Co., Ltd. of Taiwan to become an ACD Authorized Sales and Service agent for the Taiwan market. Taikkiso has a […]

Read More

CoImmune, Inc. Announces FDA Approval of its IND Application to Conduct a Phase 2b Clinical Trial with CMN-001 in Advanced RCC Patients

DURHAM, N.C., Feb. 19, 2020 (GLOBE NEWSWIRE) — CoImmune, Inc. announced today that the FDA approved its investigational new drug application (IND) and that it is cleared to move forward with a Phase 2b clinical trial in advanced metastatic renal cell carcinoma (mRCC). CMN-001, formerly known as AGS-003, is a dendritic cell-based immunotherapy custom matched […]

Read More

Media Advisory: Bombardier CEO and CFO to speak at Barclays Industrial Select Conference on February 19, 2020

MONTRÉAL, Feb. 18, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) announced today that its President and Chief Executive Officer, Alain Bellemare, and its Senior Vice President and Chief Financial Officer, John Di Bert, will speak at the Barclays Industrial Select Conference in Miami, Florida on Wednesday, February 19, at 1:50 p.m. EST DATE: Wednesday, February 19, 2020 […]

Read More

WillScot to Announce Fourth Quarter and Full Year 2019 Results and Host Investor Conference Call on March 2, 2020

BALTIMORE, Feb. 18, 2020 (GLOBE NEWSWIRE) — WillScot Corporation (“WillScot”) (Nasdaq: WSC) today announced that it will report its fourth quarter and full year 2019 financial results before the markets open on Monday, March 2, 2020. President and Chief Executive Officer, Brad Soultz, and Chief Financial Officer, Tim Boswell will also host a conference call […]

Read More